Cytokines are essential mediators of the immune response.
limitations by studying patients with active mycobacterial disMajor cytokines secreted by T helper cells are broadly categoeases. In these persons, who are currently stimulated in vivo, rized as type 1 or type 2, which are important for cell-mediated most of the circulating antigen-specific lymphocytes represent and humoral immunity, respectively. Although it has been poseffector cells that have been differentiated at the site of infectulated that the progression from human immunodeficiency vition or the draining lymph node and are in transit to and from rus (HIV) infection to AIDS may be associated with a bias lymphoid organs. The results of such a study should more toward a type 2 cytokine profile [1, 2] , intense research in this accurately reflect the influence of HIV infection on the pattern area by various methodologies have so far produced inconcluof cytokine response in these AIDS-defining diseases. sive results. However, findings on cytokine production after
The association between mycobacterial diseases and HIV mitogenic stimulation, conducted by most studies, may not infection has been well documented [5] . Tuberculosis often reliably predict the response of lymphocytes to specific antigens occurs early in the course of HIV infection, when cellular immuthat have relevance to progression to AIDS. On the other hand, nity is relatively intact [6] , in contrast to Mycobacterium avium in vitro stimulation of lymphocytes by a recall antigen leads (MAC) diseases, which are found at more advanced stages of mainly to cytokine production by memory T cell precursors AIDS [7] . The influence of cytokine response profiles on disease that had been precommitted to a Th1 or Th2 pattern years manifestations has previously been established for several myearlier [3] . Such response can differ from that of new effector cobacterial infections. A distinct dichotomy has been found cells in subsequent infection [4] . We attempted to bypass these in leprosy, in which a type 1 (interferon-g [IFN-g]) response predominates in tuberculoid leprosy, while a type 2 (interleukin-4 ) response is associated with the more severe lepromatous leprosy lesions [8] . It is also well accepted that the defense against tuberculosis depends in part on the capacity of specific JID 1998;177 (June) Cytokines in Mycobacterial Diseases with HIV stituted to 1/10 of the original volume, was added to duplicate culous granuloma to necrotic foci and pneumonia was associwells. Serially diluted recombinant human IL-4 and IFN-g (R&D ated with a shift from type 1 to type 0 (mixed) cytokine pattern Systems, Minneapolis) were used to establish standard curves.
in the lung tissue [18] . In this report, we examine the interrelaAfter 2 h at 37ЊC, plates were washed with PBS-0.05% Tween.
tionships among HIV infection, cytokine profile, and clinical They were probed sequentially, with extensive washing between manifestation of mycobacterial diseases. steps, with polyclonal rabbit anti-human IL-4 (Genzyme) or rabbit anti-human IFN-g (Calbiochem, San Diego) antibodies at 1:1000 dilution for 2 h at 37ЊC and goat anti-rabbit IgG conjugated to
Materials and Methods
horseradish peroxidase, at 1:1000 dilution for 1 h at 37ЊC. The plates were developed by the addition of enzyme substrate (20 mg Patient population. Peripheral blood samples from 29 patients at Grady Memorial Hospital (Atlanta) who had active mycobacteof o-phenylenediamine with 15 mL of H 2 O 2 in 50 mL of 0.5 M citrate buffer pH 6.0). The enzymatic reaction was stopped after rial diseases were obtained within the first week of antimycobacterial treatments, except for 1 sample that was collected 1 year after 15 min at room temperature in the dark by adding 50 mL of 4 N sulfuric acid. Optical density values measured at 490 nm were initiation of therapy. All patients were clinically ill and had cultures positive for mycobacteria from sputum, peripheral blood, or biopsy converted to cytokine concentrations based on the standard curves. The lowest concentrations detectable were 4 pg/mL for IL-4 and tissues. Seventeen patients had concomitant AIDS; the remaining 12 patients were seronegative for HIV. Among the HIV-infected 100 pg/mL for IFN-g. Since the samples were concentrated 10-fold by lyophilization before the test, the effective sensitivities of group, 10 were infected with Mycobacterium tuberculosis, and their CD4 cell counts ranged from 17 to 638 cells/mm 3 (mean, the assay system were 0.4 pg/mL for IL-4 and 10 pg/mL for IFNg per milliliter of the original culture medium. 144). The other 7 patients, who presented with MAC disease, had CD4 cell counts of 5-307 cells/mm 3 (mean, 87). Only 1 of the ELISPOT assays. IFN-g-secreting cells were counted in an ELISPOT assay, adapted from the methodology previously de-17 HIV-infected patients had previously received antiretroviral drug (zidovudine). Her HIV virus load (77,000 copies/mL) was scribed by Czerkinsky et al. [19] . Nitrocellulose 96-well plates (Millititer HA; Millipore, Bedford, MA) were coated overnight at near the median of the nontreated group (89,000 copies/mL). None cell counts and other immune parameters, continuous variables After 48 h, culture supernatants were lyophilized and stored at (e.g., total cytokine quantities) generated from individuals were 070ЊC to be assayed for cytokines by ELISA. The cells were used not normally distributed. In such cases, nonparametric measures to enumerate IFN-g-secreting cells in an ELISPOT assay.
(median and quartiles) were used in descriptive statistics, Kruskal-ELISA. IFN-g and IL-4 in culture medium were determined
Wallis one-way analysis of variance was used for comparisons of by ELISAs. Ninety-six well polystyrene plates (Immulon II; Dynatwo populations, and Spearman's rank correlation test was used to tech, Chantilly, VA) were coated with 100 mL of mouse antianalyze dependency between two parameters. Standard parametric human IL-4 monoclonal antibody (10 mg/mL; Genzyme, Camstatistics were used for normally distributed data. bridge, MA) or mouse anti-human IFN-g monoclonal antibody ( tients with active tuberculosis, the differences in cytokine profiles between HIV-infected and uninfected persons were less NOTE. /, positive; 0, negative. x 2 tests for homogeneity.
marked. There was a shift in profile from mainly type 1 (3/5, 60%) in HIV-seronegative patients to type 0 (5/9, 56%) and type 2 (2/9, 22%) in the HIV-infected patients (table 1) . The cytokine production. On the basis of ELISA results of PBMC culture medium after 48 h of PPD stimulation, the cytokine difference was due mainly to an increase in the number of persons who produced IL-4 (2/5 vs. 7/9; figure 1B), although profiles were defined as type 0 when both IFN-g and IL-4 were produced, type 1 for production of IFN-g and no detectit was not statistically significant in this small sample (P Å .26, Fisher's exact test). Restricting the analysis to only those able amounts of IL-4, and type 2 for production of IL-4 and no detectable amounts of IFN-g [2] . The cells from 3 patients who produced IL-4 (table 2), the amount of IL-4 secreted by the PBMC of the HIV-infected patients (median, 4.4 pg/mL) (2 HIV-infected, 1 HIV-seronegative) did not survive during the culture and were excluded from analysis.
was generally lower than that of the HIV-seronegative population (median, 12.0 pg/mL). With regard to IFN-g production, Cytokine profiles in mycobacterial diseases. There was no constitutive cytokine production detected in the unstimulated the proportion of IFN-g producers (7/9) in the HIV-infected population was only slightly lower than that of HIV-seronegacells. In response to PPD stimulation, the dominant cytokine pattern produced (table 1) by the HIV-infected group was type tive patients (5/5). The quantities of IFN-g generated by the HIV-infected persons (median, 72.7 pg/mL) was again lower 2 (7/15, 47%), followed by type 0 (5/15, 33%). In contrast, among the HIV-seronegative patients, the cytokine profile was than that generated by the HIV-seronegative patients (median, 1050 pg/mL). either type 0 (6/11, 55%) or type 1 (5/11, 45%). It is notable that the type 2 profile was observed only in the HIV-infected All 5 HIV-seronegative patients (3 with type 1 and 2 with type 0 cytokine patterns) had pulmonary tuberculosis. Of the population. The difference in the cytokine profiles between the 2 populations was statistically significant (P õ .05, x 2 test). HIV-infected persons, all 4 with either type 1 or type 2 patterns had localized disease, while 4 of 5 patients with type 0 profile Patients with MAC disease. When the patient population was stratified according to the mycobacterial species (M. tuberpresented with extrapulmonary tuberculosis.
Frequency of IFN-g -secreting cells. Additional informaculosis vs. M. avium), a distinct dichotomy was observed. Within the group with MAC disease, all of the HIV-seronegation on the IFN-g response was obtained by using the ELISPOT assays, which counted the number of IFN-g -secreting cells tive persons responded to PPD stimulation with IFN-g production (figure 1A), demonstrating either type 0 (4/6, 67%) or type (IFN-gSC) after in vitro PPD stimulation of PBMC. The median value for 5 of 6 HIV-infected tuberculosis patients (1 1 (2/6, 33%) profiles. By comparison, 5 of the 6 HIV-infected persons (83%) had a type 2 cytokine pattern and produced only patient not tested) was 324 IFN-gSC/10 6 PBMC (25th -75th percentile, 96 -520), lower than that of the 5 HIV-seronegative IL-4. The difference in profile distribution (table 1) between HIV-infected and HIV-seronegative persons (P Å .016, x 2 test) tuberculosis patients tested (median, 624/10 6 PBMC; 25th -75th percentile, 240 -720). The difference, however, was not can be attributed entirely to a reduction in the number of those producing IFN-g (P Å .015, Fisher's exact test), since no statistically significant due to the small sample size (P Å .35, Kruskal-Wallis one-way analysis of variance). Similar comparincrease in the number of those producing IL-4 was observed (P Å 1.00, Fisher's exact test).
ison in the MAC-infected population was not attempted because only 1 HIV-infected MAC patient produced IFN-g. The As summarized in table 2, the amount of IL-4 produced by the HIV-infected patients (median, 5.2 pg/mL) was actually amount of IFN-g produced per secreting cell in the HIV-infected persons (mean, 27.0 { 17.3 pg/cell) was similar to that lower than that of the HIV-seronegative patients (median, 8.8 pg/mL) who produced this cytokine (P Å .048). had a lower number of secreting cells than did the tuberculosis patients, irrespective of HIV infection status. Nevertheless, the average amount of IFN-g secreted per responding cell in the among the three cytokine profiles (figure 2). Kruskal-Wallis was a direct correlation between the amount of the cytokine produced and the number of CD4 / T cells (Pearson's correlaanalysis of variance by rank sum detected no significant difference in the distributions of either cell subset (P Å .75 and .18). tion coefficient Å .92, .59õRõ.98). No similar relationship was detected between IFN-g and CD8 / T cell counts (R Å When similar analyses were repeated using IFN-g or IL-4 production as the independent variates (table 3), again no statis-.27, 0.54õRõ.82), or when IL-4 production was analyzed (data not shown). tically significant correlation was found, suggesting that the cell numbers of neither cell population directly determined Correlation between cytokine responses and HIV virus load. whether the patient responded by producing either cytokine.
Plasma aliquots from the peripheral blood samples used for However, among those who produced IFN-g ( figure 3 ), there the cytokine study were available for 14 of the 15 HIV-infected patients for virus load assays. The quantity of HIV RNA copies per milliliter of plasma was compared among individuals who responded to PPD stimulation with the three cytokine profiles Table 3 . CD4 and CD8 T cell counts in patients with IFN-g and IL-4 cytokine responses to stimulation by purified protein derivative.
(figure 4). No significant difference was detected by KruskalWallis rank sum analysis (P Å .5). The median virus load in
those who produced IFN-g (38,500 copies/mL) was similar to Cell that in those who did not (49,000 copies/mL, P Å .46 other was at 1.5 million copies/mL. stimulation in 16 patients who had been tested by both methods. particular subsets of T cells, resulting in different cytokine profiles in the same individuals, as previously described in a Changes from type 1 or type 2 to type 0 were detected in 8 patients (50%). Of the 6 patients who produced IL-4 but not mouse model of experimental tuberculosis [25] . IFN-g (type 2 profile) in response to PPD stimulation (table In the current study, we have found that PPD and PHA 4), 4 responded to PHA with both IFN-g and IL-4 (type 0 induced different cytokine response profiles in 50% of the HIVprofile), suggesting that the cytokine profile shift associated infected patients with mycobacterial disease. In such cases, the with HIV infection was restricted to an antigen-induced remitogen stimulated both IFN-g and IL-4, while PPD stimulated sponse only. The remaining 2 patients produced only IL-4 when only one type of cytokine production. One could assume that stimulated by either PHA or PPD.
cytokine profile shifts occur first at the level of antigen-induced responses and can vary among different antigens before the shift can be detected with mitogenic stimulations. We believe Discussion that the response to antigen-specific stimulation should have more clinical relevance in these individuals. Clerici and Shearer [1, 2] proposed in 1994 that a shift from There are several additional major and unique advantages type 1 to type 2 cytokine phenotypes is a critical step in the provided by the mycobacterial model we used. As previously progression of HIV disease. Studies by others have generally mentioned, in testing specimens from patients with active disfailed to show a clear switch in constitutive or mitogeniceases, we were able to study effector cells recently differentistimulated cytokine production [20] , although a subtle type 1 ated under the current immunologic conditions of the patient, to type 0 shift in response to recall antigens was reported by in contrast to long-term memory cells committed previously. Maggi et al. [21] . The diverse findings may be due in part to By using a cross-reacting antigen shared by two mycobacteria differences in experimental design [22] . Cytokines produced of different virulence, which usually cause diseases at two after strong mitogenic stimulation more likely reflect the intrindifferent stages of AIDS, we can gain insight into the change sic potential of the lymphocytes. In comparison, specific antiof cytokine profiles associated with HIV disease progression. In patients with active mycobacterial diseases, the most clear-cut influence of HIV infection on cytokine production in response to PPD stimulation is the decreased IFN-g production; the effect on the IL-4 production is more subtle. Our data demonstrated that the alteration can be qualitative or quantitative, depending on the individuals and the mycobacterial species involved. The absence of IFN-g response is strongly associated with MAC diseases. This qualitative deficit is not related to the CD4 cell counts. Thus, MAC patients with 100 -300 CD4 / cells/mm 3 were likely to have a type 2 cytokine profile, while tuberculosis patients with cell counts as low as 20 were making detectable amounts of IFN-g. In comparison, almost all of the tuberculosis patients produced detectable amounts of IFN-g in response to PPD stimulation, irrespective of HIV infection status; however, a possible qualitative difference in IL-4 production was detected. Only 2 of the 5 HIV-negative tuberculosis patients responded to PPD by producing IL-4, whereas 7 of the 9 in the HIV-infected group did so. The methodology we used could not differentiate whether the same set of immune cells was responsible for both IFN-g and IL-4 production or whether a different set of cells producing IL-4 was activated in the HIV-coinfected patients. Since flow cytometric analysis of intracellular cytokines has suggested that coproduction of IFN-g and IL-4 is rare at the single-cell level [26, 27] , it is likely that an additional set of IL-4 -producing cells was involved. tively. While most HIV-infected tuberculosis patients can respond to PPD by producing IFN-g, we found that the amounts of the cytokine produced were directly related to the CD4 cell thus enhancing the chance of detecting changes in the cytokine counts of the individuals. The reduced magnitude of IFN-g profiles. Since mycobacterial diseases are among the most comresponse in HIV-infected patients with low CD4 cell counts mon manifestations of AIDS, findings from this study should was consistent with the previous findings by Lin et al. [17] and Zhang et al. [28] . Our ELISPOT results further suggest be relevant to a major portion of the HIV-infected population. 
